Zevotek Announces OTCBB Listing

Wed Mar 30, 2011 12:00pm EDT

* Reuters is not responsible for the content in this press release.

NEW YORK, March 30, 2011 (GLOBE NEWSWIRE) -- Zevotek, Inc. (OTCBB:ZVTK)
(Frankfurt:T5V2), a worldwide direct marketer and distributor of innovative
personal and home care items, today announced that the Company's shares are once
again listed on the OTCBB. Market maker Spartan Securities Group, Ltd. received
notice from FINRA (Financial Industry Regulatory Authority) that Spartan's March
24, 2011 application for OTCBB listing of Zevotek common stock was cleared
effective March 29, 2011. Last week, Zevotek announced that its shares started
listing on the OTCQB, a newly created OTCBB competitor for stocks of U.S.
registered and reporting companies that are current on their reporting to the
SEC. Spartan and other market makers recently chose to make markets in Zevotek
shares and other OTC companies on the OTCQB, where maintaining listings is less
costly for market makers.

Commenting on the announcement, Zevotek's CEO, Rob Babkie, said, "We greatly
appreciate the swift action taken by Spartan Securities and FINRA to clear
Zevotek's OTCBB listing. I am pleased that Zevotek investors today can see their
shares trading on the familiar OTCBB. The OTC marketplace is undergoing changes
that are independent of Zevotek's business. I remain committed to maintaining
Zevotek's status as a fully reporting public company whose stock trades on a
leading OTC exchange."

About the Company:

Zevotek, Inc. markets and sells a range of innovative personal and home care
items. Zevotek has a license to sell the Ionic Bulb, a patented air purifier
that silently emits negative ions using a microchip placed inside a 10,000-hour
energy saving compact fluorescent light bulb (CFL). One Ionic Bulb is an
eco-easy maintenance-free inexpensive alternative that cleans the air in a 100
square foot area. Outfitting lamps and ceiling lights with the Ionic Bulb rids a
living room, kitchen, bedroom, children's playroom, workout area and office
space of unpleasant odors and indoor air pollutants that you breathe. Zevotek
sells the Ionic Bulb through specialty retail shops, TV commercials, Amazon.com
and newionicbulb.com, and markets the Ionic Bulb to major U.S. retail stores.

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: Forward-looking statements in this release with respect to the Zevotek,
Inc.'s business, financial condition and results of operations, as well as
matters of timing and effectiveness of acquiring and selling new consumer
products are subject to risks and uncertainties that could cause actual results
to differ materially from those expressed in the forward-looking statements,
including, but not limited to, certain delays beyond Zevotek, Inc.'s control
with respect to market acceptance of their products, whether financing will be
available, the plans for Zevotek, Inc. to market and sell products as well as
certain other risk factors which are and may be detailed from time to time in
Zevotek, Inc.'s filings with the Securities and Exchange Commission.

This press release contains forward-looking statements. The words or phrases
'may,' 'intends,' 'expects,' 'estimate,' 'indicate,' 'plans,' 'anticipates,'
'could,' 'if,' 'will,' 'should' or similar expressions are intended to identify
'forward-looking statements.' Actual results could differ materially from those
projected in forward-looking statements as a result of a number of risks and
uncertainties. Statements made herein are as of the date of this press release
and should not be relied upon as of any subsequent date. Zevotek, Inc. cautions
readers not to place undue reliance on such statements. Unless otherwise
required by applicable law, Zevotek, Inc. does not undertake, and Zevotek, Inc.
specifically disclaims any obligation to update any forward- looking statements
to reflect occurrences, developments, unanticipated events or circumstances
after the date of such statement.

CONTACT: Investor relations
         info@zevo-tek.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.